Document is current
Any future updates will be listed below
-
Authors
Tse, Hung-Fat
Chang, Hung-Yu
Colquhoun, David
Kim, Jung-Sun
Poh, Kian Keong
Kostner, Karam
Hutayanon, Pisit
Cho, Meejin
Lange, Jeff
Kodiappan, Kamlanathan
Leekha, Saikiran
-
Funding
Funding for this research was provided by:
Amgen
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 6 September 2024
First Online: 25 October 2024
Declarations
:
: Hung-Fat Tse reports research funding from Abbott, AstraZeneca, Amgen, Bayer, Boehringer Ingelheim, Boston Scientific, Daiichi Sankyo, Medtronic, Novartis, Pfizer, and Sanofi. Hung-Yu Chang, Kian Keong Poh, Karam Kostner, and Pisit Hutayanon report that they have nothing to declare. David Colquhoun reports research funding from Amgen, Pfizer, AstraZeneca, Novartis, Sanofi, Bayer, and Novo Nordisk. Jung-Sun Kim reports receiving proctoring fees from Abbott Vascular. Meejin Cho, Jeff Lange, Kamlanathan Kodiappan, and Saikiran Leekha are employees and stockholders of Amgen Inc.
: Informed consent was required for patient’s participation in the study. Study protocol and informed consent forms were reviewed and approved by the institutional review board/independent ethics committee (see Supplementary Materials, Supplemental Table for full list by site). Central IRBs were used for sites in Australia and Singapore; local IRBD/ethics committees were used in all other sites. The study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments.
